Aditxt, Inc. (ADTX)Healthcare | Biotechnology | Mountain View, United States | NasdaqCM
0.43 USD
+0.00
(0.231%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.41 -0.03 (-0.027%) ⇩ (April 17, 2026, 7:59 p.m. EDT) Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:48 p.m. EDT
ADTX displays a strong bearish signal with a ~36% predicted price drop in the next month, exacerbated by a deteriorating technical structure and severe fundamental rot including -86.6% revenue contraction, insolvency (negative cash/consumption burner), and a completed reverse split signaling potential distress. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.383647 |
| AutoARIMA | 0.457092 |
| AutoETS | 1.329572 |
| MSTL | 1.346342 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 113.03 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.071 |
| Excess Kurtosis | -1.45 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 76.044 |
| Revenue per Share | 0.086 |
| Market Cap | 392,810 |
| Forward P/E | -0.04 |
| Beta | 1.40 |
| Previous Name | ADiTx Therapeutics, Inc. |
| Website | https://www.aditxt.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9997847 |
| Address1 | 2,569 Wyandotte Street |
| Address2 | Suite 101 |
| All Time High | 173,206,405,000.0 |
| All Time Low | 0.391 |
| Ask | 0.545 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 2,564,800 |
| Average Daily Volume3 Month | 641,801 |
| Average Volume | 641,801 |
| Average Volume10Days | 2,564,800 |
| Beta | 1.401 |
| Bid | 0.3033 |
| Bid Size | 2 |
| Book Value | -151.87 |
| City | Mountain View |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4343 |
| Current Ratio | 0.313 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.45 |
| Day Low | 0.4177 |
| Debt To Equity | 76.044 |
| Display Name | Aditxt |
| Earnings Timestamp End | 1,755,892,800 |
| Earnings Timestamp Start | 1,755,547,200 |
| Ebitda | -19,301,452 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.075 |
| Enterprise To Revenue | -455.479 |
| Enterprise Value | -1,455,255 |
| Eps Forward | -11.29 |
| Eps Trailing Twelve Months | -9,230.64 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.54724 |
| Fifty Day Average Change | -2.11294 |
| Fifty Day Average Change Percent | -0.82950175 |
| Fifty Two Week Change Percent | -99.97847 |
| Fifty Two Week High | 2,495.04 |
| Fifty Two Week High Change | -2,494.6057 |
| Fifty Two Week High Change Percent | -0.9998259 |
| Fifty Two Week Low | 0.391 |
| Fifty Two Week Low Change | 0.043300003 |
| Fifty Two Week Low Change Percent | 0.1107417 |
| Fifty Two Week Range | 0.391 - 2495.04 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,593,523,800,000 |
| Float Shares | 884,922 |
| Forward Eps | -11.29 |
| Forward P E | -0.03846767 |
| Free Cashflow | -18,098,088 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.08387999 |
| Gross Profits | 268 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02162 |
| Held Percent Institutions | 0.0081400005 |
| Implied Shares Outstanding | 904,469 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,773,014,400 |
| Last Split Factor | 1:8 |
| Long Business Summary | Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California. |
| Long Name | Aditxt, Inc. |
| Market | us_market |
| Market Cap | 392,810 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_551021594 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -43,101,452 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 388,921 |
| Open | 0.4495 |
| Operating Cashflow | -25,688,360 |
| Operating Margins | -10,987.256 |
| Payout Ratio | 0.0 |
| Phone | 650 870 1200 |
| Post Market Change | -0.026800007 |
| Post Market Change Percent | -6.170851 |
| Post Market Price | 0.4075 |
| Post Market Time | 1,776,470,394 |
| Prev Name | ADiTx Therapeutics, Inc. |
| Previous Close | 0.4333 |
| Price Hint | 4 |
| Price To Book | -0.0028596828 |
| Price To Sales Trailing12 Months | 122.94523 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.262 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.00100002 |
| Regular Market Change Percent | 0.230791 |
| Regular Market Day High | 0.45 |
| Regular Market Day Low | 0.4177 |
| Regular Market Day Range | 0.4177 - 0.45 |
| Regular Market Open | 0.4495 |
| Regular Market Previous Close | 0.4333 |
| Regular Market Price | 0.4343 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 280,343 |
| Return On Assets | -0.50273 |
| Return On Equity | -6.9913 |
| Revenue Growth | -0.866 |
| Revenue Per Share | 0.086 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 904,468 |
| Shares Percent Shares Out | 0.16450001 |
| Shares Short | 148,773 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 8,959 |
| Short Name | Aditxt, Inc. |
| Short Percent Of Float | 0.16450001 |
| Short Ratio | 0.84 |
| Source Interval | 15 |
| State | CA |
| Symbol | ADTX |
| Total Cash | 3,198,599 |
| Total Cash Per Share | 3.536 |
| Total Debt | 3,006,528 |
| Total Revenue | 3,195 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -9,230.64 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 356.47598 |
| Two Hundred Day Average Change | -356.0417 |
| Two Hundred Day Average Change Percent | -0.9987817 |
| Type Disp | Equity |
| Volume | 280,343 |
| Website | https://www.aditxt.com |
| Zip | 94,043 |